Financial Architects, Inc - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 84 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
Financial Architects, Inc ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2019$0500.0%0.00%
Q4 2018$0
-100.0%
500.0%0.00%
Q3 2018$1,0000.0%500.0%0.00%
Q2 2018$1,000
-50.0%
50
-28.6%
0.00%
Q1 2018$2,0000.0%700.0%0.00%
Q4 2017$2,000
-60.0%
70
-53.3%
0.00%
-100.0%
Q3 2017$5,000
-58.3%
150
-62.5%
0.00%
-50.0%
Q2 2017$12,0004000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 4,138,893$123,256,00018.11%
Broadfin Capital, LLC 1,656,720$49,337,0007.69%
SECTORAL ASSET MANAGEMENT INC 1,128,219$33,598,0003.68%
Perceptive Advisors 4,313,611$128,459,0003.60%
RTW INVESTMENTS, LP 1,122,540$33,429,0003.18%
Asymmetry Capital Management, L.P. 55,864$1,664,0002.08%
EMORY UNIVERSITY 77,335$2,303,0001.64%
Monashee Investment Management LLC 185,000$5,509,0001.52%
SPHERA FUNDS MANAGEMENT LTD. 260,000$7,743,0001.18%
Stanley-Laman Group, Ltd. 167,825$4,998,0001.14%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders